Stock listing
Artiva Biotherapeutics, Inc.
Selected listing: ARTV · NASDAQ · USD · US
Artiva Biotherapeutics, Inc. (NASDAQ:ARTV), Health Technology. Latest release Oct 2, 2026: Artiva Biotherapeutics Announces Multiple AlloNK® Data…
- Ticker
- NASDAQ:ARTV
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Other
- Exchange
- NASDAQ
- Currency
- USD
About Artiva Biotherapeutics, Inc.
Artiva Biotherapeutics, Inc. (ticker: ARTV) is a public company operating in the American market, focusing on innovative biotherapeutic solutions. The company aims to address unmet medical needs through its cutting-edge therapies.
Latest news from Artiva Biotherapeutics, Inc.
Artiva Biotherapeutics Announces Multiple AlloNK® Data Presentations at the American College of Rheumatology (ACR) Convergence 2026
October 1, 2026
Artiva Biotherapeutics Highlights Updated AlloNK® Data in Sjögren Disease Presented at the 17th International Symposium on Sjögren’s Disease (ISSjD 2026)
September 30, 2026
Artiva Biotherapeutics Announces Oral Presentation of AlloNK® Clinical Data at the 17th International Symposium on Sjögren’s Disease
September 23, 2026
Artiva Biotherapeutics to Participate in the Stifel 2026 Virtual Immunology and Inflammation Forum
September 17, 2026
Artiva Biotherapeutics Provides Update on Planned AlloNK® Data Disclosures and Development Milestones for the Remainder of 2026
September 8, 2026
Research Artiva Biotherapeutics, Inc.
Artiva Biotherapeutics, Inc. company profile
View the public company page for Artiva Biotherapeutics, Inc. on 6ix.
Artiva Biotherapeutics, Inc. news
Read company news and market updates connected to Artiva Biotherapeutics, Inc..
Artiva Biotherapeutics, Inc. investor events
Find investor webinars, events, and replay context for Artiva Biotherapeutics, Inc..